Sesh Inc.

Sesh Inc.

Company Details

WebsiteLinkedIn

Status: Private

Employees: 11-50

Location:

Washington DC, United States

Type:

sample

Technology:

sample

About: Sesh is committed to improving care for cancer patients. The newest paradigm in healthcare is precision medicine, whereby each patient is given the right treatment at the right time. This strategy leads to the best outcome. In oncology, there are many different types of treatment - from chemo, radiation, and surgery to targeted inhibitors and immunotherapy. Sesh operates at the forefront of medicine, applying a precision oncology approach to the newest and most promising type of cancer therapy, immunotherapy.Our technology, RELOAD, allows each cancer patient and their oncology team to determine whether immunotherapy is the optimal type of treatment at a given time. For many patients, immunotherapy is indeed the best option, but other patients may be unlikely to benefit from immunotherapy due to biomarkers that prevent immunotherapy from being effective. RELOAD measures the presence of these biomarkers, so that informed treatment decisions can be made. Making treatment decisions utilizing the information from RELOAD can save a patient's life.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BiopharmIQ
Sesh Inc. | Active clinical trials on ClinicalTrials.gov

Active Clinical Trials Count | 0

No Active Trials Found On ClinicalTrials.gov.